Impact Partnership Wealth LLC Takes Position in Colgate-Palmolive (NYSE:CL)

Impact Partnership Wealth LLC purchased a new position in Colgate-Palmolive (NYSE:CL) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 8,833 shares of the company’s stock, valued at approximately $803,000.

Several other hedge funds have also added to or reduced their stakes in the stock. FMR LLC raised its holdings in Colgate-Palmolive by 65.6% in the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock worth $700,642,000 after buying an additional 2,674,807 shares during the last quarter. Barclays PLC grew its stake in shares of Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after acquiring an additional 2,132,747 shares during the period. State Street Corp raised its holdings in shares of Colgate-Palmolive by 3.8% during the third quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after purchasing an additional 1,784,411 shares during the last quarter. Nordea Investment Management AB lifted its position in Colgate-Palmolive by 32.5% during the fourth quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock valued at $462,121,000 after purchasing an additional 1,247,731 shares during the period. Finally, AQR Capital Management LLC boosted its holdings in Colgate-Palmolive by 58.6% in the second quarter. AQR Capital Management LLC now owns 2,416,943 shares of the company’s stock worth $234,540,000 after purchasing an additional 892,706 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.34% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the stock. TD Cowen decreased their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Stifel Nicolaus dropped their target price on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research report on Friday, January 17th. JPMorgan Chase & Co. reduced their price target on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research report on Thursday, January 16th. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Finally, UBS Group reduced their price objective on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $101.11.

Colgate-Palmolive Trading Up 0.5 %

Shares of Colgate-Palmolive stock opened at $87.98 on Friday. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The firm’s 50 day simple moving average is $92.00 and its two-hundred day simple moving average is $97.58. Colgate-Palmolive has a 12-month low of $80.03 and a 12-month high of $109.30. The firm has a market capitalization of $71.88 billion, a price-to-earnings ratio of 25.21, a PEG ratio of 3.59 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.27%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.